300439SZSE

Announcement on the Implementation of the 2025 Annual Equity Distribution

Meikang Biotechnology Co., Ltd.··3 pages

✨ AI Summary

The announcement details the approved equity distribution plan for 2025 by Meikang Biotechnology Co., Ltd. Shareholders will receive a cash dividend of RMB 0.33 per 10 shares, totaling RMB 12,682,520.90. The record date for the distribution is June 10, 2026, with the payment date set for June 11, 2026. The plan aligns with the resolutions passed at the annual shareholders' meeting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Meikang Biotechnology Co., Ltd.
Securities Code: 300439
Securities Abbreviation: Meikang Biotechnology
Announcement No.: 2026-035

Announcement on the Implementation of the 2025 Annual Equity Distribution

The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Meikang Biotechnology Co., Ltd. (hereinafter referred to as "the Company") has approved the 2025 annual equity distribution plan at the 2025 annual shareholders' meeting held on May 22, 2026. The details of the equity distribution are announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing